Check your cortisol and ALT levels
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What ashwagandha is and how standardized extracts differ
Ashwagandha is an adaptogenic herb from the root of Withania somnifera, used in Ayurvedic medicine for centuries. Its bioactive compounds, called withanolides, are responsible for most of its physiological effects. The concentration and profile of these withanolides vary dramatically depending on how the root is extracted and processed, which is why not all ashwagandha supplements behave the same way in the body.
Two proprietary extracts dominate the clinical literature:
| Extract | Source and standardization | Studied most for |
|---|---|---|
| KSM-66 | Full-spectrum root extract standardized to at least 5% withanolides, made through a water-based extraction that preserves the natural ratio of compounds in the whole root | Stress reduction, endurance, testosterone support in men, and cognitive performance |
| Sensoril | Roots and leaves, standardized to a higher withanolide concentration (typically 10%), with a specific focus on withaferin A | Metabolic outcomes and body composition |
The distinction matters because the withanolide profile influences which pathways are activated. KSM-66's full-spectrum approach may offer broader adaptogenic effects, and Sensoril's higher withaferin A content may act more on inflammation and metabolic signaling, but these are hypotheses, not trial findings. Withanolide content also varies between products: in a lab analysis of 24 products, measured levels differed from the label by a factor of 2 to 35.
How much to take, which form, and when
Take 300 to 600 mg of a standardized root extract daily, matched to your goal:
| Goal | Extract | Daily dose | Timing | Trial length |
|---|---|---|---|---|
| Stress and cortisol | Standardized root extract (KSM-66 in the cortisol trial) | 300-600 mg (2022 meta-analysis) | Once daily or split; the cortisol trial used 300 mg twice daily | 60 days in the cortisol trial |
| Sleep quality | Root extract | 600 mg, as 300 mg twice daily (2019 RCT) | Twice daily | 10 weeks |
| Testosterone in men | KSM-66 | 600 mg, as 300 mg twice daily, with resistance training (2015 RCT) | Twice daily | 8 weeks |
Form and label
Ashwagandha studies have used various preparations and doses, so a trial result applies to the extract that was tested. Supplements typically contain root, leaf, or both extracts. The label tells you which one you have:
- Extract name and plant part, such as KSM-66 or Shoden, and whether it is root only or root and leaf
- Standardization: a stated withanolide percentage, as KSM-66 carries, and the Shoden trial delivered 21 mg of withanolide glycosides a day
- Dose per serving and servings per day, so you can add up your daily total against the 300 to 600 mg range
- A third-party seal from ConsumerLab.com, NSF International, or U.S. Pharmacopeia, which indicates the product was properly manufactured, contains the listed ingredients, and has no harmful levels of contaminants
A seal doesn't guarantee that a product is safe or effective, and FDA can't approve supplements before marketing.
Dose
How much is too much isn't well defined. Safety trials in healthy adults have tested 125 to 600 mg daily, the longest for 180 days (2026 systematic review), so there is little long-term safety data to support going higher. Sleep benefits were stronger at 600 mg a day or more and with 8 weeks or more of use (2021 meta-analysis). A gradual approach, starting at a lower dose and adjusting based on response, is commonly recommended.
Timing
Ashwagandha can be taken in the morning, evening, or split between both. Trials haven't compared times of day, so choose based on routine and how it affects you:
- Split dosing (300 mg in the morning and 300 mg in the evening) matches the twice-daily schedule used in the cortisol, sleep, and testosterone trials.
- If it makes you drowsy, evening dosing may suit you better.
- Food's effect on absorption hasn't been established.
Combinations
Ashwagandha is often combined with other adaptogens like rhodiola or holy basil, but there's no clinical evidence that these combinations are more effective than ashwagandha alone. If you're taking magnesium for sleep or stress, magnesium isn't among ashwagandha's known medication interactions, which involve drugs for diabetes, blood pressure, immune suppression, sedation, seizures, and thyroid hormone. Avoid combining ashwagandha with sedative medications such as benzodiazepines or barbiturates, alcohol, or other GABAergic compounds without medical guidance, as the effects may be additive. Ashwagandha may also stimulate the immune system.
Liver warning signs: when to stop ashwagandha
Stop taking ashwagandha and contact a clinician promptly if you notice yellowing of your skin or eyes, persistent itching, nausea, unusual tiredness, or abdominal pain. Liver injury is rare but documented. In a published case series, all patients developed jaundice and symptoms such as nausea, lethargy, itching, and abdominal discomfort 2 to 12 weeks after starting. Liver tests normalized within 1 to 5 months in four of them.
Reported cases involved 450 to 1,350 mg a day taken for 1 week to 4 months. People with existing liver disease face more risk: in an Indian case series, five patients had underlying chronic liver disease, three presented with acute-on-chronic liver failure, and all three died on follow-up. Talk with your clinician before using ashwagandha if you have liver disease.
What the clinical trials show on stress, cortisol, and sleep
The evidence is strongest for stress and cortisol, thinner for sleep and anxiety, and thinnest for cognitive performance. One critical limitation across the literature is that most trials are industry-funded and conducted in relatively healthy adults.
Stress and cortisol
The evidence for ashwagandha's effects on stress and cortisol is stronger than for most herbal adaptogens, but it's not uniform across all populations or outcomes. In a 60-day trial of 64 adults with a history of chronic stress, 600 mg a day of KSM-66 lowered stress-scale scores and reduced serum cortisol by 27.9% from baseline, compared with 7.9% on placebo. Pooled results are less consistent: a 2025 meta-analysis found lower cortisol but no significant effect on perceived-stress scores.
Sleep
For sleep, a 10-week trial in 60 adults with insomnia and anxiety found that 300 mg twice daily shortened the time to fall asleep and improved sleep efficiency and sleep quality compared with placebo. Across five trials, the overall effect on sleep was small, and larger in people diagnosed with insomnia. How ashwagandha helps sleep isn't established.
Anxiety
For anxiety, a 2022 meta-analysis of 12 trials found lower anxiety and stress scores than placebo, but the trials varied widely and the certainty of the evidence was rated low.
Cognitive performance
For cognitive performance, the data is thinner. A few small trials using KSM-66 or magnesium L-threonate combined with ashwagandha have shown improvements in memory and reaction time, but these findings need replication in larger, well-controlled studies. The cognitive effects are likely secondary to stress reduction rather than direct nootropic action.
How ashwagandha modulates the HPA axis and cortisol rhythm
Beyond lowering cortisol, ashwagandha modulates the hypothalamic-pituitary-adrenal axis, the body's central stress response system. Under chronic stress, the HPA axis becomes hyperreactive, leading to elevated morning cortisol, blunted cortisol awakening response, and disrupted diurnal rhythm. Withanolides appear to dampen this overactivation through several pathways.
GABA-A receptors
In lab studies, ashwagandha root extract activated GABA-A receptors, the main inhibitory receptors in the brain, though less strongly than GABA itself, and its two main withanolides did not activate them. Whether this matters at supplement doses in people is unknown.
Glucocorticoid receptor sensitivity
One hypothesis is that withanolides influence glucocorticoid receptor sensitivity, which affects how cells respond to cortisol signaling. When the HPA axis is chronically activated, glucocorticoid receptors can become desensitized, leading to a state where cortisol is elevated but less effective. Ashwagandha may help restore receptor sensitivity, allowing the body to respond appropriately to stress without overproducing cortisol.
DHEA-S
Ashwagandha may also affect DHEA-S, an adrenal androgen that counteracts some of cortisol's catabolic effects, but results point in different directions. In a 60-day trial in stressed adults, ashwagandha lowered both morning cortisol and DHEA-S compared with placebo. In an 8-week trial in older, overweight men, DHEA-S rose 18% more than on placebo, while cortisol didn't change.
The daily cortisol curve
Chronic stress flattens the daily cortisol curve, which normally peaks within 30 minutes of waking, leading to elevated evening cortisol and disrupted sleep. Trials have mostly measured ashwagandha's effect on morning cortisol, so its effect on the evening part of the curve hasn't been shown.
Who responds best and who should exercise caution
Adults with high stress
Trials of ashwagandha for stress have mostly enrolled adults with high self-reported stress or subclinical anxiety, so the evidence applies best to them. If you're not experiencing significant stress, there's little evidence that you'll notice a benefit.
Men and women
Men may see modest testosterone increases. In an 8-week crossover trial in overweight men aged 40 to 70, a different standardized extract (Shoden) raised salivary testosterone 14.7% more than placebo. In an 8-week trial of young men starting resistance training, 600 mg a day of KSM-66 raised testosterone more than placebo. Neither trial tested men with diagnosed hypogonadism. Ashwagandha's hormone effects in women are less studied. In one 60-day trial, testosterone rose over time in men but not women. If you have polyendocrine metabolic ovarian syndrome (PMOS, formerly polycystic ovary syndrome) or another hormone condition, check with your clinician first.
Older adults
Older adults may also benefit: in a small 8-week trial of healthy adults aged 60 to 85, 300 mg of root extract twice daily improved quality-of-life and fitness-test scores more than placebo. Ashwagandha can lower blood glucose and blood pressure, which may require dose adjustments in medications for diabetes or hypertension, so older adults taking them should be monitored.
Who should avoid ashwagandha
Specific populations should avoid or use extreme caution with ashwagandha:
- Pregnant and breastfeeding women should avoid ashwagandha. Safety in pregnancy hasn't been established, though a 2025 systematic review found the evidence that it harms a pregnancy inconclusive.
- People with autoimmune or thyroid disorders, including Hashimoto's thyroiditis, generally shouldn't take ashwagandha, which may also exacerbate autoimmune activity in some cases.
- Those with Graves' disease or hyperthyroidism should not take ashwagandha.
- People with hormone-sensitive prostate cancer should avoid ashwagandha, because it may increase testosterone levels.
- If you're taking medications metabolized by CYP3A4 enzymes, ask your clinician first, because ashwagandha root extract changed CYP3A4 activity in human liver cells in the lab.
Cycling, tolerance, and whether you need to take breaks
What the evidence says
The question of whether to cycle ashwagandha is not settled by the clinical literature, because most studies are short and don't assess what happens with continuous use. The rationale for cycling is based on the concern that the body may adapt to the HPA axis modulation, reducing the supplement's effectiveness over time. This is plausible but not proven.
Common cycling schedules
Some practitioners recommend a 2-weeks-on, 1-week-off cycle, or a 3-months-on, 1-month-off cycle, to lower the likelihood of tolerance. The logic is that taking periodic breaks allows the HPA axis to reset and reduces the likelihood of downregulation of the receptors ashwagandha acts on. However, there's no direct evidence that tolerance develops with continuous use, and some users report sustained benefits for six months or longer without cycling.
Testing a break
If you've been taking ashwagandha for several months and notice diminishing effects, a break of two to four weeks is reasonable to assess whether the benefit returns, though no trial has tested whether breaks improve results or safety. If it does, that suggests some degree of tolerance had developed. If it doesn't, the initial benefit may have been placebo or the underlying stressor may have resolved.
Reassessing whether you still need it
Another reason to cycle is to reassess whether you still need it. Ashwagandha is not a long-term solution to chronic stress; it's a tool to support the body while you address the root causes. If you've been taking it for three months and your stress levels haven't improved, the issue may not be cortisol dysregulation but something else entirely (like sleep deprivation, poor nutrition, or unresolved psychological stressors).
The safety of taking ashwagandha every day long-term
Most clinical trials run only 8 to 12 weeks, leaving the safety of continuous long-term use inadequately studied. Beyond the liver injury covered above, one 2026 report documented adrenal suppression that persisted six months after stopping.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Side effects, interactions, and what to watch for
Ashwagandha was well tolerated for up to about 3 months in many clinical trials, but side effects do occur:
- The most common are gastrointestinal (including nausea, diarrhea, and stomach upset), particularly at higher doses or when taken on an empty stomach.
- Drowsiness is another reported side effect and can occur at any time of day.
- Thyroid function changes are a more serious concern, as ashwagandha can increase T3 and T4 levels (a change studied in subclinical hypothyroidism, but problematic in individuals with normal or elevated thyroid function).
If you're on thyroid medication, monitor TSH, free T3, and free T4 regularly, as dose adjustments may be needed.
Tracking cortisol, thyroid, and liver markers
Symptom relief is an incomplete measure, because subjective stress scores don't always track cortisol. Biomarker results have limits too. Cortisol is normally highest in the morning and much lower by late afternoon, and stress and exercise can raise it, so compare results drawn at the same time of day. A change in DHEA-S alone doesn't show the supplement is working.
Ask your clinician about checking TSH, free T3, and free T4 at baseline and after 3 months, plus hs-CRP for low-grade inflammation. Testing before you start and again after 3 months shows whether your levels changed, but a single cortisol result can't confirm that the supplement caused the change. Liver enzymes (ALT and AST) are worth checking if you use ashwagandha long-term at higher doses, and sleep quality or heart rate variability tracked on a wearable can add objective data.
Ashwagandha safe-use checklist
Run through these points before you start and again at each reassessment:
- Choose a standardized extract and confirm the extract name and withanolide percentage on the label
- Stay inside the studied dose range
- Start low and adjust based on response
- Expect mild stomach upset, loose stools, or drowsiness
- Reassess after about 3 months to decide whether you still need it
- Skip it if you are pregnant or breastfeeding or have hormone-sensitive prostate cancer, and don't start it without your clinician's go-ahead if you are about to have surgery or live with an autoimmune or thyroid disorder
- Check interactions with a pharmacist or clinician before combining it with any medicine
- Stop and contact a clinician promptly if liver warning signs appear
Check your cortisol, thyroid, and liver markers with Superpower
Most people judge ashwagandha by how they feel, and that is the measure the research supports least: in pooled trials, cortisol fell while perceived stress didn't change significantly. Withanolide content can also stray far from the label, and thyroid and liver changes are read from blood work, not from how calm you feel.
A Superpower membership includes 100+ biomarkers in a single draw, among them cortisol, DHEA-S, TSH, total T4, hs-CRP, ALT, and AST, so you start ashwagandha knowing where those numbers sit. Your results feed a personalized protocol, so stress support starts from your own data rather than a trial average, and the marketplace carries supplements at up to 20% off.
Start your Superpower membership and get your baseline in one draw.
References
- Akhgarjand C, Asoudeh F, Bagheri A, Kalantar Z, Vahabi Z, Shab-Bidar S, Rezvani H, Djafarian K (2022). Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. *Phytotherapy research : PTR*, *36*(11), 4115-4124. https://doi.org/10.1002/ptr.7598
- Chandrasekhar K, Kapoor J, Anishetty S (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. *Indian J Psychol Med*, *34*(3), 255–62. https://doi.org/10.4103/0253-7176.106022
- Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D (2019). Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. *Cureus*, *11*(9), e5797. https://doi.org/10.7759/cureus.5797
- Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. *J Int Soc Sports Nutr*, *12*, 43. https://doi.org/10.1186/s12970-015-0104-9
- Office of Dietary Supplements, National Institutes of Health (2025). Ashwagandha: Is it helpful for stress, anxiety, or sleep? Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/
- National Center for Complementary and Integrative Health (2023). Ashwagandha: Usefulness and Safety. https://www.nccih.nih.gov/health/ashwagandha
- Lopresti AL, Drummond PD, Smith SJ (2019). A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males. *American journal of men's health*, *13*(2), 1557988319835985. https://doi.org/10.1177/1557988319835985
- Office of Dietary Supplements, National Institutes of Health (2023). Dietary Supplements: What You Need to Know. https://ods.od.nih.gov/factsheets/WYNTK-Consumer/
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- Coope OC, Willems MET, Levington A, Tallon MJ, Roman-Viñas B, Spurr TJ (2026). Back to the Roots: Safety and Tolerability of Standardised Ashwagandha (Withania somnifera) Root Extract in Healthy Adults-A Systematic Review of Biomarkers and Adverse Events. *Pharmaceuticals (Basel, Switzerland)*, *19*(5), 725. https://doi.org/10.3390/ph19050725
- Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R (2021). Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. *PloS one*, *16*(9), e0257843. https://doi.org/10.1371/journal.pone.0257843
- Björnsson HK, Björnsson ES, Avula B, et al (2020). Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. *Liver Int*, *40*(4), 825–829. https://doi.org/10.1111/liv.14393
- Philips CA, Valsan A, Theruvath AH, et al (2023). Ashwagandha-induced liver injury-A case series from India and literature review. *Hepatol Commun*, *7*(10). https://doi.org/10.1097/HC9.0000000000000270
- Albalawi AA (2025). Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress - A systematic review and meta-analysis. *Nutr Health*, *31*(4), 1395–1408. https://doi.org/10.1177/02601060251363647
- Candelario M, Cuellar E, Reyes-Ruiz JM, et al (2015). Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. *J Ethnopharmacol*, *171*, 264–72. https://doi.org/10.1016/j.jep.2015.05.058
- Lopresti AL, Smith SJ, Malvi H, Kodgule R (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. *Medicine*, *98*(37), e17186. https://doi.org/10.1097/MD.0000000000017186
- Honnutagi R, Ingale A, Naikawdi A (2026). Ashwagandha ( Withania somnifera ) Root Extract Improves General Health in Elderly Men and Women: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study. *Phytother Res*, *40*(8), 4932–4945. https://doi.org/10.1002/ptr.70125
- Tallon MJ, Koturbash I, Blum JL (2025). A Systematic and Ethnobotanical Review of Ashwagandha's (Withania Somnifera) Teratogenic and Abortifacient Potentials. *Phytotherapy research : PTR*. https://doi.org/10.1002/ptr.70079
- Javid J, Kunnuru SR, Anne B, Muskan S (2026). From herbal hope to hormonal havoc: chronic ashwagandha use and HPA axis suppression. *Endocrinol Diabetes Metab Case Rep*, *2026*(1), pii: EDM250076. doi: 10.1530/EDM-25-0076. https://doi.org/10.1530/EDM-25-0076
- Tharakan A, Shukla H, Benny IR, Tharakan M, George L, Koshy S (2021). Immunomodulatory Effect of Withania somnifera (Ashwagandha) Extract-A Randomized, Double-Blind, Placebo Controlled Trial with an Open Label Extension on Healthy Participants. *J Clin Med*, *10*(16). https://doi.org/10.3390/jcm10163644
- Zellner L, Wierer M, Himmelsbach M, Schatzmann B, Thalhamer B, Klampfl CW (2025). Determination of Withanolides and Withanosides in Ashwagandha Based Products Using HPLC-Drift-Tube-Ion-Mobility Quadrupole Time-of-Flight Mass Spectrometry. *Electrophoresis*, *46*(5-6), 340–346. https://doi.org/10.1002/elps.202400188
- McDonald KL, Raichura Z, Pondugula SR, et al (2025). Ashwagandha (Withania somnifera) Plant Extracts Affect the Cytochrome P450 System and Cytotoxicity of Primary Human Hepatocytes. *J Diet Suppl*, *22*(4), 613–639. https://doi.org/10.1080/19390211.2025.2514458
- MedlinePlus, National Library of Medicine (2024). Cortisol Test. https://medlineplus.gov/lab-tests/cortisol-test/


















